COMPARATIVE IMMUNOLOGICAL CHARACTERISTICS OF INHALATION AND COMBINED ANESTHESIA IN CANCER PATIENTS
- Authors: Tanatarov S.Z1, Neimark M.I2, Cherepkova E.V3,4, Gorbatenko A.E1
-
Affiliations:
- State Medical University Semey
- The Altay state of medical university
- Physiology research institute
- Siberian Independent Institute
- Issue: Vol 18, No 1 (2013)
- Pages: 39-42
- Section: Articles
- Published: 15.02.2013
- URL: https://rjonco.com/1028-9984/article/view/39974
- DOI: https://doi.org/10.17816/onco39974
- ID: 39974
Cite item
Full Text
Abstract
The purpose of research is a comparative characterization of inhalation and inhalation-epidural anesthesia influence on the state of the cellular mechanisms of antitumor immunity in patients with malignant tumors of the gastrointestinal tract. The study included 181 patients with gastric cancer, pancreatic cancer, who received radical surgery aged 40-70 years. Indices of immune system cellular component in relation to anesthesia - inhalation anesthetic sevoflurane or a combination of inhalation and epidural anesthesia - at 3 and 7 days after surgery were evaluated. The study revealed the Reduction of negative effects of surgery and anesthesia on cell component of the immune system during the application of the combined method of inhalation anesthesia.
Full Text
Сравнительная иммунологическая характеристика ингаляционного и комбинированного наркоза у онкологических больных×
About the authors
S. Z Tanatarov
State Medical University Semey
Email: sayat68@mail.ru
071400, Semey, Republic of Kazakhstan
M. I Neimark
The Altay state of medical university656038, Barnaul, Russian Federation
E. V Cherepkova
Physiology research institute; Siberian Independent Institute630117, Novosibirsk; Russian Federatio
A. E Gorbatenko
State Medical University Semey071400, Semey, Republic of Kazakhstan
References
- de Souza A. P., Bonorino C. The immune system: endogenous anticancer mechanism. Front Biosci (Elite Ed). 2012; 4: 2354—64.
- Facciabene A., Motz G. T., Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012; 72 (9): 2162—71.
- Tan P. H., Lota A. S. Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics. Expert Opin. Pharmacother. 2008; 9 (15): 2639—60.
- Littlewood K. E. The immunocompromised adult patient and surgery. Best Pract. Res. Clin. Anaesthesiol. 2008; 22 (3): 585—609.
- Kurosawa S., Kato M. Anesthetics, immune cells, and immune responses. J. Anesth. 2008; 22 (3): 263—77.
- Kurosawa S. Anesthesia in patients with cancer disorders. Curr. Opin. Anaesthesiol. 2012; 25 (3): 376—84.
- Szczesny T., Slotwinski R., Szczesny G. Changes in humoral and cellular immunity in patients operated on due to esophageal cancer. Pol. Merkur. Lekarski. 2005; 18 (106): 478—82.